Clinically relevant drug interactions with multikinase inhibitors: a review
KGAM Hussaarts, GDM Veerman… - … in medical oncology, 2019 - journals.sagepub.com
Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
Clinically relevant drug interactions with multikinase inhibitors: a review
KGAM Hussaarts, GDM Veerman… - … Advances in Medical …, 2019 - cir.nii.ac.jp
抄録< jats: p> Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs),
have rapidly become an established factor in daily (hemato)-oncology practice. Although the …
have rapidly become an established factor in daily (hemato)-oncology practice. Although the …
Clinically relevant drug interactions with multikinase inhibitors: a review.
KGAM Hussaarts, GD Veerman… - Therapeutic …, 2019 - search.ebscohost.com
Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
Clinically relevant drug interactions with multikinase inhibitors: a review
K Hussaarts, GDM Veerman, F Jansman… - … Advances in Medical …, 2019 - repub.eur.nl
Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
[HTML][HTML] Clinically relevant drug interactions with multikinase inhibitors: a review
KGAM Hussaarts, GDM Veerman… - … Advances in Medical …, 2019 - ncbi.nlm.nih.gov
Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
[PDF][PDF] Clinically relevant drug interactions with multikinase inhibitors: a review
KGAM Hussaarts, GDM Veerman, FGA Jansman… - 2019 - core.ac.uk
Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
Clinically relevant drug interactions with multikinase inhibitors: a review.
K Hussaarts, GDM Veerman, FGA Jansman… - … Advances in Medical …, 2019 - europepmc.org
Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
Clinically relevant drug interactions with multikinase inhibitors: a review
KGAM Hussaarts, GDM Veerman… - Therapeutic …, 2019 - pubmed.ncbi.nlm.nih.gov
Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
Clinically relevant drug interactions with multikinase inhibitors: A review
KGAM Hussaarts, GDM Veerman… - … advances in medical …, 2019 - research.rug.nl
Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
Clinically relevant drug interactions with multikinase inhibitors: a review.
KGAM Hussaarts, GD Veerman… - Therapeutic …, 2019 - search.ebscohost.com
Multikinase inhibitors (MKIs), including the tyrosine kinase inhibitors (TKIs), have rapidly
become an established factor in daily (hemato)-oncology practice. Although the oral route of …
become an established factor in daily (hemato)-oncology practice. Although the oral route of …